Literature DB >> 10586041

Negative regulation of CD4 lineage development and responses by CD5.

C Peña-Rossi1, L A Zuckerman, J Strong, J Kwan, W Ferris, S Chan, A Tarakhovsky, A D Beyers, N Killeen.   

Abstract

CD5 deficiency results in a hyper-responsive phenotype to Ag receptor stimulation. Here we show that the development and responses of CD4 lineage T cells are regulated by the function of CD5. Thymocytes expressing the I-Ad-restricted DO11.10 TCR undergo abnormal selection without CD5. In H-2d mice, the absence of CD5 causes deletion of double-positive thymocytes, but allows for efficient selection of cells expressing high levels of the DO11.10 clonotype. By contrast, there is enhanced negative selection against the DO11.10 clonotype in the presence of I-Ab. T cell hybridomas and DO11.10 T cells are more responsive to TCR stimulation in the absence of CD5. Such hypersensitivity can be eliminated by expression of wild-type CD5, but not by a form of CD5 that lacks the cytoplasmic tail. Finally, CD5 deficiency partially suppresses the block of CD4 lineage development in CD4-deficient mice. Taken together, the data support a general role for CD5 as a negative regulator of Ag receptor signaling in the development and immune responses of CD4 lineage T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586041

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Dynamic expression of multiple scavenger receptor cysteine-rich genes in coelomocytes of the purple sea urchin.

Authors:  Z Pancer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  The E47 transcription factor negatively regulates CD5 expression during thymocyte development.

Authors:  Yang Yang; Christopher H Contag; Dean Felsher; Catherine M Shachaf; Yuan Cao; Leonard A Herzenberg; Leonore A Herzenberg; James W Tung
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-04       Impact factor: 11.205

3.  How alpha beta T cells deal with induced TCR alpha ablation.

Authors:  B Polic; D Kunkel; A Scheffold; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

4.  Exonal switch down-regulates the expression of CD5 on blasts of acute T cell leukaemia.

Authors:  A K Rai; A Singh; A Saxena; T Seth; V Raina; D K Mitra
Journal:  Clin Exp Immunol       Date:  2017-09-05       Impact factor: 4.330

5.  Histone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytes.

Authors:  Herbert G Kasler; Eric Verdin
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

Review 6.  The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development.

Authors:  Amanda L Prince; Catherine C Yin; Megan E Enos; Martin Felices; Leslie J Berg
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  Tuning T Cell Signaling Sensitivity Alters the Behavior of CD4+ T Cells during an Immune Response.

Authors:  Ashley A Viehmann Milam; Juliet M Bartleson; David L Donermeyer; Stephen Horvath; Vivek Durai; Saravanan Raju; Haiyang Yu; Veronika Redmann; Bernd Zinselmeyer; J Michael White; Kenneth M Murphy; Paul M Allen
Journal:  J Immunol       Date:  2018-04-04       Impact factor: 5.422

8.  CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation.

Authors:  Courtney A Matson; Seeyoung Choi; Ferenc Livak; Bin Zhao; Apratim Mitra; Paul E Love; Nevil J Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

9.  A ligand for CD5 is CD5.

Authors:  Marion H Brown; Erica Lacey
Journal:  J Immunol       Date:  2010-10-15       Impact factor: 5.422

10.  CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.

Authors:  Namir J Hassan; Stephen J Simmonds; Nicholas G Clarkson; Sarah Hanrahan; Michael J Puklavec; Martine Bomb; A Neil Barclay; Marion H Brown
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.